Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jieying Chen & Guangyu Tang. (2019) PIM-1 kinase: a potential biomarker of triple-negative breast cancer. OncoTargets and Therapy 12, pages 6267-6273.
Read now
Read now
Ezekiel Maloney, Tanya Khokhlova, Venu G. Pillarisetty, George R. Schade, Elizabeth A. Repasky, Yak-Nam Wang, Lorenzo Giuliani, Matteo Primavera & Joo Ha Hwang. (2017) Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy. International Reviews of Immunology 36:6, pages 338-351.
Read now
Read now
Yuan-Bo Wu, Di Lu, Zhi-Feng He & Chan-Guan Jin. (2016) PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population. OncoTargets and Therapy 9, pages 2919-2925.
Read now
Read now
Nidhi Singh, Prasenjit Das, Siddhartha Datta Gupta, Peush Sahni, R. M. Pandey, Surabhi Gupta, Shyam S. Chauhan & Anoop Saraya. (2013) Prognostic Significance of Extracellular Matrix Degrading Enzymes—Cathepsin L and Matrix Metalloproteases-2 [MMP-2] in Human Pancreatic Cancer. Cancer Investigation 31:7, pages 461-471.
Read now
Read now
Sailay Siddiqi & Mark A Sussman. (2013) Cell and gene therapy for severe heart failure patients: The time and place for Pim-1 kinase. Expert Review of Cardiovascular Therapy 11:8, pages 949-957.
Read now
Read now
Dapeng Xu, Michael G. Cobb, Lily Gavilano, Sam M. Witherspoon, Daniel Williams, Catherine D. White, Pietro Taverna, Brian K. Bednarski, Hong Jin Kim, Albert S. Baldwin & Antonio T. Baines. (2013) Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine. Cancer Biology & Therapy 14:6, pages 492-501.
Read now
Read now
Priyanka Sharma, Anoop Saraya, Prerna Gupta & Rinu Sharma. (2013) Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers 18:4, pages 322-330.
Read now
Read now
Anna Lena Merkel, Eric Meggers & Matthias Ocker. (2012) PIM1 kinase as a target for cancer therapy. Expert Opinion on Investigational Drugs 21:4, pages 425-436.
Read now
Read now
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu, Eleonora Codorean & Simona Olimpia Dima. (2009) Biomarkers in the diagnosis and early detection of pancreatic cancer. Expert Opinion on Medical Diagnostics 3:5, pages 533-546.
Read now
Read now
Articles from other publishers (71)
Komala Ingle, Joseph F. LaComb, Lee M. Graves, Antonio T. Baines & Agnieszka B. Bialkowska. (2023) AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLOS ONE 18:11, pages e0294065.
Crossref
Crossref
Avinoam Nevler, Saed Khalilieh, Harish Lavu, Wilbur Bowne & Charles J Yeo. (2023) Hypercapnic Tissue Gene Expression and Survival in Early-Stage Pancreatic Ductal Adenocarcinoma. Journal of the American College of Surgeons 236:4, pages 913-922.
Crossref
Crossref
Paul J. Smith, Stephanie R. McKeown & Laurence H. Patterson. (2022)
Targeting
DNA
topoisomerase
IIα
(
TOP2A
) in the hypoxic tumour microenvironment using unidirectional hypoxia‐activated prodrugs (
uHAPs
)
. IUBMB Life 75:1, pages 40-54.
Crossref
Crossref
Xavier León, Jacinto García, Albert Pujol, Julia de Juan, Rosselin Vásquez, Miquel Quer & Mercedes Camacho. (2022) Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy. European Archives of Oto-Rhino-Laryngology 279:7, pages 3679-3684.
Crossref
Crossref
Sutapa Mahata, Pranab K. Sahoo, Ranita Pal, Sinjini Sarkar, Tanuma Mistry, Sushmita Ghosh & Vilas D. Nasare. (2022) PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer. Medical Oncology 39:7.
Crossref
Crossref
Lin Lai, Xinyu Chen, Ge Tian, Renba Liang, Xishan Chen, Yuelan Qin, Kaihua Chen & Xiaodong Zhu. (2022) Clinical Significance of Pim-1 in Human Cancers: A Meta-analysis of Association with Prognosis and Clinicopathological Characteristics. Cancer Control 29, pages 107327482211062.
Crossref
Crossref
Iman M. Ahmad, Alicia J. Dafferner, Kelly A. O’Connell, Kamiya Mehla, Bradley E. Britigan, Michael A. Hollingsworth & Maher Y. Abdalla. (2021) Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers 13:9, pages 2264.
Crossref
Crossref
Gillian Moore, Clara Lightner, Samira Elbai, Lauren Brady, Siobhan Nicholson, Ronan Ryan, Katie E. O’Sullivan, Kenneth J. O’Byrne, Carmen Blanco-Aparicio, Sinead Cuffe, Michael O’Neill, Susan Heavey, Stephen P. Finn & Kathy Gately. (2021) Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC. Cancers 13:9, pages 2139.
Crossref
Crossref
Ameneh Jafari, Mostafa Rezaei-Tavirani, Behrouz Farhadihosseinabadi, Hakimeh Zali & Hassan Niknejad. (2021) Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
David E Ebeid, Farid G Khalafalla, Kathleen M Broughton, Megan M Monsanto, Carolina Y Esquer, Veronica Sacchi, Nirmala Hariharan, Kelli I Korski, Maryam Moshref, Jacqueline Emathinger, Christopher T Cottage, Pearl J Quijada, Jonathan H Nguyen, Roberto AlvarezJrJr, Mirko Völkers, Mathias H Konstandin, Bingyan J Wang, Fareheh Firouzi, Julian M Navarrete, Natalie A Gude, Marie-Jose Goumans & Mark A Sussman. (2021) Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling. Cardiovascular Research 117:1, pages 201-211.
Crossref
Crossref
Yanan Li, Ying Cheng, Maoqi Zhang, Xiaoli He, Li Kong, Kexiang Zhou, Yunfu Zhou, Lin Li, Hongqi Tian, Xiaomin Song & Yukun Cui. (2020) A New Compound with Increased Antitumor Activity by Cotargeting MEK and Pim-1. iScience, pages 101254.
Crossref
Crossref
Qian Li, Chuanwu Jiang, Yan Wang, Minghua Wei, Huijin Zheng, Yanqi Xu, Xuegang Xu, Fengyu Jia, Kai Liu, Gang Sun, Jianhua Zang & Ping Mo. (2020) RETRACTED ARTICLE: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1. Naunyn-Schmiedeberg's Archives of Pharmacology 392:12, pages 1477-1489.
Crossref
Crossref
Faramarz Rahmatizadeh, Shiva Gholizadeh-Ghaleh Aziz, Khodadad KhodadadiMaryam Lale AtaeiEsmaeil EbrahimieJafar Soleimani RadMaryam Pashaiasl. (2019) Bidirectional and Opposite Effects of Naïve Mesenchymal Stem Cells Ontumor Growth and Progression. Advanced Pharmaceutical Bulletin 9:4, pages 539-558.
Crossref
Crossref
Maher Y. Abdalla, Iman M. Ahmad, Satyanarayana Rachagani, Kasturi Banerjee, Christopher M. Thompson, H. Carlo Maurer, Kenneth P. Olive, Katie L. Bailey, Bradley E. Britigan & Sushil Kumar. (2019) Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. Translational Research 207, pages 56-69.
Crossref
Crossref
Lianjing Cao, Fan Wang, Shouying Li, Xinyue Wang, Dingzhi Huang & Richeng Jiang. (2019) PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway. Cancer Letters 444, pages 116-126.
Crossref
Crossref
Kaili Liu, Hui Gao, Qiaoyun Wang, Longyuan Wang, Bin Zhang, Zhiwu Han, Xuehong Chen, Mei Han & Mingquan Gao. (2018)
Retracted:
Hispidulin suppresses cell growth and metastasis by targeting
PIM
1
through
JAK
2/
STAT
3 signaling in colorectal cancer
. Cancer Science 109:5, pages 1369-1381.
Crossref
Crossref
Bin Zhao, Lei Liu, Jun Mao, Zhiwei Zhang, Qifei Wang & Quanlin Li. (2018) PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis. Cell Death & Disease 9:3.
Crossref
Crossref
Mirosława Koronkiewicz, Zdzisław Chilmonczyk, Zygmunt Kazimerczuk & Andrzej Orzeszko. (2018) Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents. European Journal of Pharmacology 820, pages 146-155.
Crossref
Crossref
Shi Wen, Bohan Zhan, Jianghua Feng, Weize Hu, Xianchao Lin, Jianxi Bai & Heguang Huang. (2017) Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling. BMC Cancer 17:1.
Crossref
Crossref
Lubna Swellmeen, Rand Shahin, Yusuf Al-Hiari, Amani Alamiri, Alaa Hasan & Omar Shaheen. (2017) Structure based drug design of Pim-1 kinase followed by pharmacophore guided synthesis of quinolone-based inhibitors. Bioorganic & Medicinal Chemistry 25:17, pages 4855-4875.
Crossref
Crossref
Manuel-Pedro Jiménez-García, Antonio Lucena-Cacace, María-José Robles-Frías, Irene Ferrer, Maja Narlik-Grassow, Carmen Blanco-Aparicio & Amancio Carnero. (2017) Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus. Oncotarget 8:35, pages 58872-58886.
Crossref
Crossref
Shuya Wang, Zhengyi Cao, Junhui Xue, Hui Li, Wei Jiang, Yuning Cheng, Gang Li & Xiaowei Zhang. (2017) A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis. Journal of Biological Chemistry 292:20, pages 8207-8222.
Crossref
Crossref
Amany Mawas, Vishwa Amatya, Rui Suzuki, Kei Kushitani, Mouchira Mohi El-Din & Yukio Takeshima. (2017) PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells. International Journal of Oncology.
Crossref
Crossref
Jianwei Xu, Guangbing Xiong, Zhe Cao, Hua Huang, Tianxiao Wang, Lei You, Li Zhou, Lianfang Zheng, Ya Hu, Taiping Zhang & Yupei Zhao. (2016) PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Manuel Pedro Jiménez-García, Antonio Lucena-Cacace, María José Robles-Frías, Maja Narlik-Grassow, Carmen Blanco-Aparicio & Amancio Carnero. (2016) The role of PIM1/PIM2 kinases in tumors of the male reproductive system. Scientific Reports 6:1.
Crossref
Crossref
Shuai Mou, Guangbin Wang, Ding Ding, Dongdong Yu, Yi Pei, Songling Teng & Qin Fu. (2016) Expression and function of PIM kinases in osteosarcoma. International Journal of Oncology 49:5, pages 2116-2126.
Crossref
Crossref
Hao Gu, Mingzhu Liu, Changmao Ding, Xin Wang, Rui Wang, Xinyu Wu & Ruitai Fan. (2016)
Hypoxia‐responsive miR‐124 and miR‐144 reduce hypoxia‐induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing
PIM
1
. Cancer Medicine 5:6, pages 1174-1182.
Crossref
Crossref
F F Blanco, M Jimbo, J Wulfkuhle, I Gallagher, J Deng, L Enyenihi, N Meisner-Kober, E Londin, I Rigoutsos, J A Sawicki, M V Risbud, A K Witkiewicz, P A McCue, W Jiang, H Rui, C J Yeo, E Petricoin, J M Winter & J R Brody. (2015) The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene 35:19, pages 2529-2541.
Crossref
Crossref
Zi-Ran Wei, Chao Liang, Dan Feng, Ya-Jun Cheng, Wei-Min Wang, De-Jun Yang, Yue-Xiang Wang & Qing-Ping Cai. (2016) Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer. Oncotarget 7:14, pages 17737-17750.
Crossref
Crossref
Vishwa Amatya, Amany Mawas, Kei Kushitani, Mouchira Mohi El-Din & Yukio Takeshima. (2016) Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma. International Journal of Oncology.
Crossref
Crossref
S. Kreuz, K. B. Holmes, R. M. Tooze & P. F. Lefevre. (2015) Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. Molecular Cancer 14:1.
Crossref
Crossref
Noel A. Warfel & Andrew S. Kraft. (2015) PIM kinase (and Akt) biology and signaling in tumors. Pharmacology & Therapeutics 151, pages 41-49.
Crossref
Crossref
Yang Liu & Lianfang Du. (2015) Role of pancreatic stellate cells and periostin in pancreatic cancer progression. Tumor Biology 36:5, pages 3171-3177.
Crossref
Crossref
Zhongyu Liu, Weihua He, Jianglin Gao, Junhua Luo, Xian Huang & Chunfang Gao. (2015) Computational prediction and experimental validation of a novel synthesized pan-PIM inhibitor PI003 and its apoptosis-inducing mechanisms in cervical cancer. Oncotarget 6:10, pages 8019-8035.
Crossref
Crossref
Joshua A. McCarroll, George Sharbeen, Jie Liu, Janet Youkhana, David Goldstein, Nigel McCarthy, Lydia F. Limbri, Dominic Dischl, Güralp O. Ceyhan, Mert Erkan, Amber L. Johns, Andrew V. Biankin, Maria Kavallaris & Phoebe A. Phillips. (2014) βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer. Oncotarget 6:4, pages 2235-2249.
Crossref
Crossref
Susann Herzog, Matthias Alexander Fink, Kerstin Weitmann, Claudius Friedel, Stefan Hadlich, Sönke Langner, Katharina Kindermann, Tobias Holm, Andreas Böhm, Eskil Eskilsson, Hrvoje Miletic, Markus Hildner, Michael Fritsch, Silke Vogelgesang, Christoph Havemann, Christoph Alexander Ritter, Henriette Elisabeth Meyer zu Schwabedissen, Bernhard Rauch, Wolfgang Hoffmann, Heyo Klaus Kroemer, Henry Schroeder & Sandra Bien-Möller. (2015) Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival. Neuro-Oncology 17:2, pages 223-242.
Crossref
Crossref
Koremu Meja, Chloe Stengel, Rob Sellar, Dennis Huszar, Barry R. Davies, Rosemary E. Gale, David C. Linch & Asim Khwaja. (2014) PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways. British Journal of Haematology 167:1, pages 69-79.
Crossref
Crossref
Bo Jin, Yu Wang, Chen Lin Wu, Kai Yu Liu, Hao Chen & Ze Bin Mao. (2014)
PIM
‐1 modulates cellular senescence and links
IL
‐6 signaling to heterochromatin formation
. Aging Cell 13:5, pages 879-889.
Crossref
Crossref
Jonathan Haqq, Lynne M Howells, Giuseppe Garcea, Matthew S Metcalfe, Will P Steward & Ashley R Dennison. (2014) Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies. European Journal of Cancer 50:15, pages 2570-2582.
Crossref
Crossref
Jianwei Xu, Taiping Zhang, Tianxiao Wang, Lei You & Yupei Zhao. (2014) PIM kinases: an overview in tumors and recent advances in pancreatic cancer. Future Oncology 10:5, pages 865-876.
Crossref
Crossref
Angela Alexander & Khandan Keyomarsi. 2014. Nuclear Signaling Pathways and Targeting Transcription in Cancer. Nuclear Signaling Pathways and Targeting Transcription in Cancer
337
372
.
Maja Narlik-Grassow, Carmen Blanco-Aparicio & Amancio Carnero. (2014) The PIM Family of Serine/Threonine Kinases in Cancer. Medicinal Research Reviews 34:1, pages 136-159.
Crossref
Crossref
Yong-hai Peng, Jian-jun Li, Fang-wei Xie, Jian-fang Chen, Ying-hao Yu, Xue-nong Ouyang & Hou-jie Liang. (2013) Expression of pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients. PLoS ONE 8:10, pages e76693.
Crossref
Crossref
Carmen Blanco-Aparicio & Amancio Carnero. (2013) Pim kinases in cancer: Diagnostic, prognostic and treatment opportunities. Biochemical Pharmacology 85:5, pages 629-643.
Crossref
Crossref
Jun Yin, Lisa Shine, Francis Raycroft, Sudhakar Deeti, Alison Reynolds, Kristin M. Ackerman, Antonino Glaviano, Sean O'Farrell, Olivia O'Leary, Claire Kilty, Ciaran Kennedy, Sarah McLoughlin, Megan Rice, Eileen Russell, Desmond G. Higgins, David R. Hyde & Breandan N. Kennedy. (2012) Inhibition of the Pim1 Oncogene Results in Diminished Visual Function. PLoS ONE 7:12, pages e52177.
Crossref
Crossref
M Sahraei, L D Roy, J M Curry, T L Teresa, S Nath, D Besmer, A Kidiyoor, R Dalia, S J Gendler & P Mukherjee. (2012) MUC1 regulates PDGFA expression during pancreatic cancer progression. Oncogene 31:47, pages 4935-4945.
Crossref
Crossref
Mert Erkan, Simone Hausmann, Christoph W. Michalski, Alexander A. Fingerle, Martin Dobritz, Jörg Kleeff & Helmut Friess. (2012) The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nature Reviews Gastroenterology & Hepatology 9:8, pages 454-467.
Crossref
Crossref
Katherine M. Block, Neale T. Hanke, Erin A. Maine & Amanda F. Baker. (2012) IL-6 Stimulates STAT3 and Pim-1 Kinase in Pancreatic Cancer Cell Lines. Pancreas 41:5, pages 773-781.
Crossref
Crossref
Jui-Ling Hsu, Pui-Kei Leong, Yunn-Fang Ho, Lih-Ching Hsu, Pin-Hsuan Lu, Ching-Shih Chen & Jih-Hwa Guh. (2012) Pim-1 knockdown potentiates paclitaxel-induced apoptosis in human hormone-refractory prostate cancers through inhibition of NHEJ DNA repair. Cancer Letters 319:2, pages 214-222.
Crossref
Crossref
Beverly W. BaronJohn AnastasiElizabeth M. HyjekJuraj Bies, Poluru L. ReddyJingfang Dong, Loren JosephMichael J. Thirman, Kristen Wroblewski, Linda Wolff & Joseph M. Baron. (2012)
PIM1
gene cooperates with human
BCL6
gene to promote the development of lymphomas
. Proceedings of the National Academy of Sciences 109:15, pages 5735-5739.
Crossref
Crossref
Megan B. Wachsmann, Laurentiu M. Pop & Ellen S. Vitetta. (2023) Pancreatic Ductal Adenocarcinoma: A Review of Immunologic Aspects. Journal of Investigative Medicine 60:4, pages 643-663.
Crossref
Crossref
Sara Chiblak, Fevzi Demircioglu, Azadeh Fahim Golestaneh & Amir Abdollahi. 2012. Systems Biology in Cancer Research and Drug Discovery. Systems Biology in Cancer Research and Drug Discovery
135
164
.
Vera Magistroni, Luca Mologni, Stefano Sanselicio, James Frances Reid, Sara Redaelli, Rocco Piazza, Michela Viltadi, Giorgio Bovo, Guido Strada, Marco Grasso, Manuela Gariboldi & Carlo Gambacorti-Passerini. (2011) ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells. PLoS ONE 6:11, pages e28162.
Crossref
Crossref
Cristina Gómez-AbadHelena PisoneroCarmen Blanco-Aparicio, Giovanna RoncadorAlberto González-Menchén, Jose A. Martinez-Climent, Eva MataMaría Elena RodríguezGuillermo Muñoz-GonzálezMargarita Sánchez-BeatoJuan F. Leal, James R. Bischoff & Miguel A. Piris. (2011) PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood 118:20, pages 5517-5527.
Crossref
Crossref
Alexander Herner, Danguole Sauliunaite, Christoph W. Michalski, Mert Erkan, Tiago De Oliveira, Ivane Abiatari, Bo Kong, Irene Esposito, Helmut Friess & Jörg Kleeff. (2011)
Glutamate increases pancreatic cancer cell invasion and migration
via
AMPA receptor activation and Kras‐MAPK signaling
. International Journal of Cancer 129:10, pages 2349-2359.
Crossref
Crossref
Tamar Samkharadze, Mert Erkan, Carolin Reiser-Erkan, Ihsan Ekin Demir, Bo Kong, Güralp O Ceyhan, Christoph W Michalski, Irene Esposito, Helmut Friess & Jörg Kleeff. (2011) Pigment Epithelium-Derived Factor Associates With Neuropathy and Fibrosis in Pancreatic Cancer. American Journal of Gastroenterology 106:5, pages 968-980.
Crossref
Crossref
D. Xu, S. A. Allsop, S. M. Witherspoon, J. L. Snider, J. J. Yeh, J. J. Fiordalisi, C. D. White, D. Williams, A. D. Cox & A. T. Baines. (2011) The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells. Carcinogenesis 32:4, pages 488-495.
Crossref
Crossref
Szabolcs Fatrai, Albertus T. J. Wierenga, Simon M. G. J. Daenen, Edo Vellenga & Jan Jacob Schuringa. (2011) Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells. Blood 117:12, pages 3320-3330.
Crossref
Crossref
Siri Dunér, Jacob Lopatko Lindman, Daniel Ansari, Chinmay Gundewar & Roland Andersson. (2011) Pancreatic Cancer: The Role of Pancreatic Stellate Cells in Tumor Progression. Pancreatology 10:6, pages 673-681.
Crossref
Crossref
Martijn C. Nawijn, Andrej Alendar & Anton Berns. (2010) For better or for worse: the role of Pim oncogenes in tumorigenesis. Nature Reviews Cancer 11:1, pages 23-34.
Crossref
Crossref
Sophie Vasseur, Richard Tomasini, Roselyne Tournaire & Juan L. Iovanna. (2010) Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness. Cancers 2:4, pages 2138-2152.
Crossref
Crossref
Mert Erkan, Nadine Weis, Zheng Pan, Christian Schwager, Tamar Samkharadze, Xiaohua Jiang, Ute Wirkner, Nathalia A. Giese, Wilhelm Ansorge, Jürgen Debus, Peter E. Huber, Helmut Friess, Amir Abdollahi & Jörg Kleeff. (2010) Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Molecular Cancer 9:1.
Crossref
Crossref
Hong-Tao Liu, Ning Wang, Xin Wang & Sheng-Lei Li. (2010) Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Journal of Surgical Oncology 102:6, pages 683-688.
Crossref
Crossref
Weibin Wang, Carolin Reiser-Erkan, Christoph W. Michalski, Matthias C. Raggi, Liao Quan, Zhao Yupei, Helmut Friess, Mert Erkan & Jörg Kleeff. (2010) Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Biochemical and Biophysical Research Communications 401:3, pages 422-428.
Crossref
Crossref
Nancy S Magnuson, Zeping Wang, Gang Ding & Raymond Reeves. (2010) Why target PIM1 for cancer diagnosis and treatment?. Future Oncology 6:9, pages 1461-1478.
Crossref
Crossref
Miriam López‐Ramos, Renaud Prudent, Virginie Moucadel, Céline F. Sautel, Caroline Barette, Laurence Lafanechère, Liliane Mouawad, David Grierson, Frédéric Schmidt, Jean‐Claude Florent, Panagis Filippakopoulos, Alex N. Bullock, Stefan Knapp, Jean‐Baptiste Reise & Claude Cochet. (2010) New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights. The FASEB Journal 24:9, pages 3171-3185.
Crossref
Crossref
Marina Zemskova, Michael B. Lilly, Ying-Wei Lin, Jin H. Song & Andrew S. Kraft. (2010) p53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase. Molecular Cancer Research 8:8, pages 1126-1141.
Crossref
Crossref
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu & Mihail Eugen Hinescu. 2010.
145
180
.
John P. Neoptolemos, Raul Urrutia, James L. Abbruzzese & Markus W. BüchlerMert Erkan, Irene Esposito, Helmut Friess & Jörg Kleeff. 2010. Pancreatic Cancer. Pancreatic Cancer
535
563
.
Jian Chen, Masanobu Kobayashi, Stephanie Darmanin, Yi Qiao, Christopher Gully, Ruiying Zhao, Satoshi Kondo, Hua Wang, Huamin Wang, Sai-Ching Jim Yeung & Mong-Hong Lee. (2009) Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation. The American Journal of Pathology 175:1, pages 400-411.
Crossref
Crossref
Mert Erkan, Carolin Reiser-Erkan, Christoph W. Michalski, Stefanie Deucker, Danguole Sauliunaite, Sylvia Streit, Irene Esposito, Helmut Friess & Jörg Kleeff. (2009) Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma. Neoplasia 11:5, pages 497-508.
Crossref
Crossref